key: cord-0866030-3juehieh
authors: Ambrosch, Andreas; Rockmann, Felix; Klawonn, Frank; Lampl, Benedikt
title: Effect of a strict hygiene bundle for the prevention of nosocomial transmission of SARS-CoV-2 in the hospital: a practical approach from the field
date: 2020-10-20
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2020.10.005
sha: 8aa1de8714e0e87495d5a5066c890b42c41f06f2
doc_id: 866030
cord_uid: 3juehieh

BACKGROUND: During the novel coronavirus disease (COVID-19) pandemic it is crucial for hospitals to implement infection prevention strategies to reduce nosocomial transmission to the lowest possible number. This is all the more important because molecular tests for identifying SARS-CoV-2 infected patients are uncertain, and the resources available for them are limited. In this view, a monocentric, retrospective study with an interventional character was conducted to investigate the extent to which the introduction of a strict hygiene bundle including a general mask requirement and daily screening for suspicious patients has an impact on the SARS-CoV-2 nosocomial rate in the pandemic environment. METHODS: All inpatients from a maximum care hospital in Regensburg (Bavaria) between March 1(st) and June 10(th) 2020 were included. Patient with respiratory symptoms were tested for SARS-CoV-2 at admission, patients were managed according to a standard hygiene protocol. At the end of March a strict hygiene bundle was introduced including a general mask obligation and a daily clinical screening of inpatients for respiratory symptoms. Nosocomial infection rate for COVID-19 and the risk for infection transmission estimated by the nosocomial incidence density before and after introduction the hygiene bundle were compared. The infection pressure for the hospital during the entire observational period was characterized by the infection reports in the region in relation to the number of hospitalized COVID-19 patients and the number of infected employees. RESULTS: In fact, after the introduction of a strict hygiene bundle including a general mouth and nose protection obligation and a daily clinical screening of suspicious patients, a significant reduction of the nosocomial rate from 0.28 to 0.06 (p = 0.026) was observed. Furthermore, the risk of spreading hospital-acquired infections also decreased dramatically from 0.0007 to 0.00018 (p = 0.031; rate ratio after/before 0.25 (95%CI 0.06, 1.07) despite a slow decrease of the hospital COVID 19-prevalence and an increase of infected employees. CONCLUSION: The available data underline that a strict hygiene bundle seem to be associated with a decrease of nosocomial SARS-CoV-2 transmission in the pandemic situation.

In recent years, hospital-acquired infections have become one of the major problems that threaten human health in the world. In addition to the growing number of cases, the presence of multidrug-resistant (MDR) isolates makes the treatment increasingly difficult [1] .

Pseudomonas aeruginosa is one of the most important causes of hospital-acquired infections, and the adequacy of disinfection processes as well as antibiotic resistance for infection control has become an important step. Biocides are chemical substances that are applied to provide sanitation of the hospital surfaces and medical devices. Especially, disinfectants play an essential role in infection control and the prevention of nosocomial transmission of infectious microorganisms. Therefore, choosing the right disinfectant and applying it at the right doses is an important step for controlling the infection [2] .

Microorganisms form biofilms to protect themselves from disinfectants and antimicrobials [3] . It is also known that biofilm production which allows the cells to be embedded in the poly matrix structure makes it harder to remove bacteria from the surfaces of environments and medical devices. This main virulence factor which is critical for hospital sanitation is regulated by a number of mechanisms, and one of them is called quorum sensing (QS) in which many genes are involved and related to environmental conditions and stress response [4] . In this sense, considering the effects of disinfection applications and their effects on biofilm formation will provide important data for the reduction of nosocomial infections [5] .

In recent studies, it was declared that Pseudomonas spp. can adapt or develop resistance to CHX quite easily. Exposure to sub-lethal concentrations of CHX a substantial increase of J o u r n a l P r e -p r o o f the MIC was observed from 10 to 70 mg/L. Researchers stated that this effect may be caused by biofilm production [6, 7] . In two studies, biocides have been shown to induce biofilm production in Pseudomonas spp. [8, 9] . In a study, MIC values of CHX and antibiofilm efficacy in Pseudomonas isolates were investigated [10] . As a result, it has been shown that disinfectant activity against planktonic cells was detected, but it did not affect bacterial cells in biofilm even at concentrations higher than MIC of CHX. Many microorganisms acquire resistance to disinfectants and can adapt to changing environmental conditions. The mechanisms in cell-cell signaling, genetic diversity, nutritional shortages and inappropriate use of disinfectants may also affect the resistance of biofilms to antibiotics [10] .

Bacteria have been shown to communicate by using QS processes to coordinate population behaviour in response to environmental factors. The large number of QS-regulated genes that encode virulence genes were identified in the past [11] . P. aeruginosa and Acinetobacter baumannii are important nosocomial pathogens and coordinate the formation of biofilms and their expression of virulence factors through QS [12] . QS is a system that regulates gene expression at high cell densities and plays critical role in bacterial infections [12] . In P. aeruginosa, QS is highly complex and two interlinked regulatory systems acting both at the transcriptional and posttranscriptional levels [13] . The las and rhl systems regulate gene expression of virulence factors in P. aeruginosa, and las system consists of LasR (transcriptional activator) and LasI, which is responsible for the synthesis of autoinducer N-(3-oxododecanoyl) homoserine lactone. The rhl system consists of RhlR (transcriptional activator) and RhlI, which directs the synthesis of N-butyryl homoserine lactone [14] . It is also known that QS plays a key role in the regulation of biofilm production in addition to bacterial virulence. An important problem related to QS is the ability of P. aeruginosa to form a biofilm matrix that provides bacterial cells a protected environment withstanding various stresses including antibiotics [15] . It is important to inhibit the QS-related virulence and J o u r n a l P r e -p r o o f biofilm of P. aeruginosa in order to contribute to the field of infection control and antimicrobial resistance.

This study aimed to determine the inhibitory concentrations of ciprofloxacin, polyhexanide, chlorhexidine gluconate, glutaraldehyde and quaternary ammonium compounds, and to investigate the effects of different disinfectant doses on biofilm production and QS-related gene expression alterations on clinical P. aeruginosa isolates.

Pseudomonas aeruginosa isolates were collected from Ege University, Faculty of Medicine, Department of Medical Microbiology, Bacteriology Laboratory, and the isolates were determined as genetically unrelated by ERIC-PCR and strong biofilm producer by a spectrophotometric method in our previous study [16] . Virulence characteristics of nine isolates [Lipase (6 positive), twitching (6 positive), pigment (7 pyoverdin and 1 pyocyanin), elastase (9 positive), protease (3 positive), siderophore (9 positive)] were also reported in our previous study [16] . Bacterial isolates were stored in brain-heart infusion broth (BHIB) (Merck, USA) with 10% glycerine at -80°C.

Glutaraldehyde (GLU) (Doganay, Turkey) (2.0%), quaternary ammonium compounds (QAC) (Dr. Schumacher, Germany) (0.05%), polyhexanide (PHMB) (Mertsel, Turkey) (0.2%) and chlorhexidine gluconate (CHX) (Merkez Ilac, Turkey) (2.0%) were disinfectants used in this study. Ciprofloxacin (Kocak Farma, Turkey) was used as an antibiotic agent in this study. Disinfectants and ciprofloxacin were dissolved in distilled water to prepare stock solutions and dilutions. 

Minimum inhibitory concentrations of disinfectants were determined to study the antibiofilm activity of disinfectants. For this purpose, the well plate method was used [18] . The MIC was defined as the lowest concentration of the agent that inhibits the visible growth of the tested isolate. Pseudomonas aeruginosa ATCC 15442 strain was used for the quality control.

Bacterial isolates were inoculated on MHA and incubated at 35°C for 24 h. Bacterial suspensions were prepared by using 0.9% sodium chloride and adjusted to 0. (TSB medium) were also studied. After incubation at 35°C for 24 h, the medium was removed from the wells using a micropipette. Then spectrophotometric microtiter-plate test method using crystal violet (CV) staining was performed by a spectrophotometer (Thermo-Scientific, Varioskan) [19] . All experiments were performed in triplicate and the mean values were evaluated.

To determine the effects of disinfectants and ciprofloxacin on mature biofilm, CV method was used as previously described. Incubation without agents at 35°C for 24 h were performed in order to mature biofilm on microplate surface. After biofilm formation, the medium in wells was aspirated, and all wells washed with sterile PBS. MIC, MIC/2, MIC/4 concentrations of disinfectants and ciprofloxacin were added to wells, and microplates incubated for a further 24 h at 35°C. Then, CV staining assay was performed [19] .

Antibiofilm effects of the agents were evaluated by measuring the optical density (O.D.) values by spectrophotometrically. All experiments were performed in triplicate.

Real time reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was performed to investigate the effects of CIP and disinfectants at MIC levels on the expression of lasI, lasR, rhlI and rhlR genes in three isolates that were CIP-susceptible and strong biofilm producer. acpP (housekeeping gene) was used as a control to normalize data. Primers used in this study are shown in Table 1 [20, 21] .

Bacteria were grown on MHA at 35°C overnight. Approximately 1.5×10 8 hours. The optical density of bacterial cells was adjusted to equal levels. All experiments were performed in triplicate. One mL of each bacterial suspensions was used in the RNA isolation procedure.

Bacterial suspensions (1 mL of each) were centrifuged, and total RNA was extracted from the pellets with GeneJET RNA Purification Kit (Thermo Scientific, USA) following the manufacturer's instructions. Total RNA concentrations were measured by spectrophotometer (NanoVette, Beckman Coulter), and each sample was adjusted to equal levels using sterile double distilled water.

Total RNA samples (2 nanograms of each) were used to synthesize cDNA using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, USA) according to the manufacturer's instructions. cDNA samples were 1/50 diluted, and RT-qPCR experiments were performed. All experiments were performed in triplicate, and RNA/cDNA samples were stored at -80°C.

Light Cycler 480 SYBR Green I Master (Roche) was used in the reactions following the manufacturer's instructions with 1 µL of each cDNA and primers. PCR reactions were performed under the following conditions: One cycle/5 min at 95°C, followed by 45 cycles/10 sec at 95°C, 10 sec at 43°C and 10 sec at 72°C. Light Cycler 480 II (Roche, Switzerland) J o u r n a l P r e -p r o o f device was used for real-time PCR, and threshold cycle (CT) values were calculated using LC480 1.5 software program.

Statistical analyses were performed by GraphPad program using t-test. A p-value of less than 0.05 was considered to be statistically significant.

Minimum inhibitory concentrations of disinfectants and CIP are presented in Table 2 .

According to microdilution method results, three isolates were found to be resistant, one isolate was found to be intermediate susceptible and five isolates were found to be susceptible to CIP. CHX (7.81-31.25 µg/mL) had the lowest MIC values, whereas GLU (1250-5000 µg/mL), QAC and PHMB MIC values were found 9.77-78.13 µg/mL and 0.12-1.95 µg/mL, respectively.

According to the results, MIC and sub-MIC levels of the agents reduced or induced the biofilm production levels of P. aeruginosa isolates. Statistically significant test results (p ≤ 0.05) were summarized in Table 3 , 4 and 5. According to the results, CHX inhibited the biofilm production levels of eight of nine isolates, and GLU and CIP inhibited the biofilm production levels of six of nine isolates in the presence of agents at MIC levels. Biofilm production levels of five of nine isolates were also inhibited in the presence of GLU at MIC/2 levels. In contrast, biofilm production levels of two isolates and one isolate were induced in the presence of QAC and GLU at MIC levels, respectively.

J o u r n a l P r e -p r o o f According to the results, MIC and sub-MIC levels of the agents reduced or induced mature biofilm levels of P. aeruginosa isolates. Statistically significant test results (p ≤ 0.05) were presented in Table 3 , 4 and 5. According to the results, GLU inhibited the mature biofilm levels of three of nine isolates at MIC and MIC/4 levels and four of nine isolates at MIC/2 levels. CIP also inhibited the mature biofilm levels of the isolates at MIC and sub-MIC levels. Also, it was found that mature biofilm levels of some isolates were induced in the presence of QAC, PHMB, CHX and CIP at different concentrations.

The effects of disinfectants and ciprofloxacin on gene expression levels of P.

aeruginosa isolates were demonstrated in Table 6 . According to the results of gene expression experiments, lasI gene of isolate #177 was significantly upregulated in the presence of GLU and PHMB at MIC levels after 24 h incubation, and biofilm production levels were downregulated in the same conditions. lasR gene of isolate #177 was found to be downregulated in the presence of GLU and CIP in parallel to the inhibition of biofilm production in the same conditions. In contrast to this finding, lasR gene of isolate #67 and #70 was upregulated in the presence of CHX, whereas the biofilm production of the isolates was found to be inhibited by CHX. In parallel to the inhibition of biofilm production levels, rhlI and rhlR genes of isolate #177 were downregulated in the presence of GLU and CIP. rhlR gene of isolate #70 was also upregulated in the presence of GLU, PHMB and CHX, while biofilm production levels were inhibited with the addition of the agents.

The number of hospital-acquired infections has been growing since the 1980s.

Although many different bacterial species could cause nosocomial infections, an opportunistic non-fermentative bacterium named P. aeruginosa is one of the most common. In addition to this spread, the emergence of MDR isolates caused increased morbidity and mortality rates J o u r n a l P r e -p r o o f worldwide. Due to this situation attention should be paid not only to the treatment but also to the prevention of the spread of these resistant isolates [18] .

The main points of this control are the prevention of both contamination of surfaces and the formation of biofilm which ensures that the surfaces hold firmly. To achieve this goal, disinfectants and biocides should be used in appropriate dosages. Although the studies on antibiotic resistance have been performed from many different health institutions, the number of studies investigating the efficiency of disinfectants and the effects of these agents on biofilm production is quite few [18, 22] . In addition, there are no breakpoints to define resistance to biocides. Epidemiological data about the definition of biocide resistance is extremely limited [23, 24] . Although there are guidelines for antibiotics worldwide, there are no specific standard values for disinfectants [25] . Minimum inhibitory concentrations refer to the lowest substance dose that prevents bacterial growth. These values are considered as an indicator of resistance or susceptibility and in this way, clinicians can use these concentrations to pretend as a criterion to measure the success of treatment. Disinfectant MIC values were determined in very few studies [18] .

In this study, the MIC and MBC values of all disinfectants were determined and the lowest MIC value was determined as CHX against isolates, followed by PHMB, QAC and 2% GLU, respectively. Although it is controversial whether MICs of disinfectants infers resistance or not, it is suggested in some studies that, 4-8 fold increase in the MIC values can reduce susceptibility [26] . In view of this criterion, disinfectant resistance was not observed in the isolates in our study.

In our country, except for CHX, there are no studies with biocides similar to our study to the best of our knowledge. Chlorhexidine gluconate was found effective against P.

aeruginosa in former studies [27] [28] [29] . In a study conducted in Iran, Gram-negative bacteria were more tolerant to disinfectant compared to Gram-positive bacteria [30] . This is thought to J o u r n a l P r e -p r o o f be due to the less permeable cell wall of Gram-negative bacteria, and the prevalence of efflux pump structures that will expel molecules that enter the cell.

In this study, CHX (7.81-31.25 µg/mL) had the lowest MIC values against clinical P. aeruginosa isolates when compared to the other disinfectants. Also, CHX inhibited the biofilm production levels of eight of nine isolates, and GLU and CIP inhibited the biofilm production levels of six of nine isolates at MIC levels. It is also found that GLU inhibited the According to the results of several studies investigating the expression of QS-related genes, it was found that active substances such as salicylic acid, trans-cinnamaldehyde, N-(2pyrimidinyl) butanamide and alginate oligomer that have different chemical structure may affect the expression of QS genes generally in downregulation way [31] [32] [33] . Considering the literature, targeting the QS-related genes may be a reasonable strategy for the inhibition of biofilm in clinical P. aeruginosa isolates.

Pseudomonas aeruginosa causes severe and persistent infections in humans, and its infections are hard to eradicate because of the resistance development to many antimicrobials and disinfectants. In conclusion, our findings highlight the inhibitory effects of studied agents.

CHX had the lowest MIC against P. aeruginosa isolates when compared to other disinfectants, and inhibited the biofilm production levels of 89% of the isolates at MIC levels. 

None. Table 5 . Effects of ciprofloxacin on biofilm production and mature biofilm (% inhibition/induction and p values) 

Nosocomial infections: Epidemiology, prevention, control and surveillance

Determination of Minimum inhibitory concentrations of Common Biocides to Multidrug-Resistant Gram-negative bacteria

Impact of growth temperature and surface type on the resistance of Pseudomonas aeruginosa and Staphylococcus aureus biofilms to disinfectants

Antibacterial-resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms

Effects of Chlorine Stress on Pseudomonas aeruginosa Biofilm and Analysis of Related Gene Expressions

Acquired resistance to chlorhexidine -is it time to establish an 'antiseptic stewardship' initiative?

Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a "residual" concentration

Adaptation of

Pseudomonas aeruginosa clinical isolates to benzalkonium chloride retards its growth and enhances biofilm production

Effect of antimicrobial residues on early adhesion and biofilm formation by wild-type and benzalkonium chloride-adapted Pseudomonas aeruginosa

Chlorhexidine activity against bacterial biofilms

Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: Effects of growth phase and environment

Exploiting quorum sensing ınhibition for the control of pseudomonas aeruginosa and acinetobacter baumannii biofilms

Quorum sensing: The power of cooperation in the world of Pseudomonas

Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes

The hierarchy quorum sensing network in Pseudomonas aeruginosa

The virulence characteristics and epidemiological relationship of clinical Pseudomonas aeruginosa isolates

Performance Standards for Antimicrobial Susceptibility Testing A CLSI supplement for global application

Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii-A first report from the Kingdom of Saudi Arabia

A modified microtiter-plate test for quantification of Staphylococcal biofilm formation

Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa

Potent antibacterial antisense peptide-peptide nucleic acid conjugates against Pseudomonas aeruginosa

Antiseptics and Disinfectants: Activity, Action, and

Biocide susceptibilities and biofilm-forming capacities of

Evaluation of epidemiological cut-off values indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms

Development and evaluation of a broth macrodilution method to determine the biocide susceptibility of bacteria

Mechanisms of antimicrobial action of antiseptics and disinfectants: An increasingly important area of investigation

An investigation of the bactericidal activity of chlorhexidine digluconate against multidrug-resistant hospital isolates

Karasahan Yağcı A. Biofilm production and biocidal efficacy Negative Bacteria

Antimicrobial Activity of Chlorhexidine, Peracetic acid/ Peroxide hydrogen and Alcohol based compound on Isolated Bacteria in Madani Heart Hospital

Pseudomonas aeruginosa virulence factors

Alginate oligosaccharide-induced modification of the lasI-lasR and rhlI-rhlR quorum-sensing systems in Pseudomonas aeruginosa

Impairment of Pseudomonas aeruginosa biofilm resistance to antibiotics by combining the drugs with a new quorumsensing inhibitor